BGB 3111 in Combination With Obinutuzumab in Participants With B-Cell Lymphoid Malignancies
Clinical trial NCT02569476 · COMPLETED
Trial details
- NCT number
- NCT02569476
- Sponsor
- BeiGene
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-01-13
- Primary completion
- 2020-09-02
- Enrollment
- 119
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.